X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Emami Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs EMAMI LTD - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES EMAMI LTD AMAR REMEDIES/
EMAMI LTD
 
P/E (TTM) x -0.5 77.5 - View Chart
P/BV x 0.1 14.0 0.4% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 AMAR REMEDIES   EMAMI LTD
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
EMAMI LTD
Mar-17
AMAR REMEDIES/
EMAMI LTD
5-Yr Chart
Click to enlarge
High Rs1641,260 13.0%   
Low Rs86916 9.4%   
Sales per share (Unadj.) Rs261.6109.8 238.2%  
Earnings per share (Unadj.) Rs17.415.0 116.1%  
Cash flow per share (Unadj.) Rs22.328.6 78.0%  
Dividends per share (Unadj.) Rs07.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs100.777.3 130.3%  
Shares outstanding (eoy) m26.16226.97 11.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.59.9 4.8%   
Avg P/E ratio x7.272.6 9.9%  
P/CF ratio (eoy) x5.638.1 14.7%  
Price / Book Value ratio x1.214.1 8.8%  
Dividend payout %046.7 0.0%   
Avg Mkt Cap Rs m3,270246,898 1.3%   
No. of employees `000NA3.1 0.0%   
Total wages/salary Rs m1632,336 7.0%   
Avg. sales/employee Rs ThNM8,049.9-  
Avg. wages/employee Rs ThNM754.1-  
Avg. net profit/employee Rs ThNM1,097.8-  
INCOME DATA
Net Sales Rs m6,84424,930 27.5%  
Other income Rs m21311 6.8%   
Total revenues Rs m6,86525,241 27.2%   
Gross profit Rs m1,1317,591 14.9%  
Depreciation Rs m1283,086 4.1%   
Interest Rs m398580 68.6%   
Profit before tax Rs m6264,236 14.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121836 14.5%   
Profit after tax Rs m4553,400 13.4%  
Gross profit margin %16.530.4 54.3%  
Effective tax rate %19.319.7 97.9%   
Net profit margin %6.613.6 48.7%  
BALANCE SHEET DATA
Current assets Rs m4,9044,579 107.1%   
Current liabilities Rs m3,5817,776 46.1%   
Net working cap to sales %19.3-12.8 -150.8%  
Current ratio x1.40.6 232.5%  
Inventory Days Days12426 473.7%  
Debtors Days Days10014 705.2%  
Net fixed assets Rs m1,6897,633 22.1%   
Share capital Rs m262227 115.4%   
"Free" reserves Rs m2,35817,320 13.6%   
Net worth Rs m2,63517,547 15.0%   
Long term debt Rs m5070-   
Total assets Rs m6,86226,127 26.3%  
Interest coverage x2.68.3 31.0%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.0 104.5%   
Return on assets %12.415.2 81.6%  
Return on equity %17.319.4 89.1%  
Return on capital %31.027.4 112.9%  
Exports to sales %4.02.9 136.1%   
Imports to sales %00-   
Exports (fob) Rs m273731 37.4%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m273911 30.0%   
Fx outflow Rs m2468 0.4%   
Net fx Rs m271443 61.2%   
CASH FLOW
From Operations Rs m-3137,296 -4.3%  
From Investments Rs m-489-2,975 16.4%  
From Financial Activity Rs m769-4,958 -15.5%  
Net Cashflow Rs m-33-721 4.5%  

Share Holding

Indian Promoters % 25.5 70.6 36.1%  
Foreign collaborators % 0.0 2.2 -  
Indian inst/Mut Fund % 9.2 1.3 707.7%  
FIIs % 0.0 16.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 9.2 709.8%  
Shareholders   13,061 25,076 52.1%  
Pledged promoter(s) holding % 99.7 19.5 511.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   GODREJ CONSUMER  KARUTURI GLOBAL  RELAXO FOOTWEARS  BAJAJ CORP  MARICO LTD  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS